BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 1999
View Archived Issues
Preliminary phase II results promising for Maxamine in HCV
Read More
LeukoSite announces important milestone, merger
Read More
Esteve sublicenses Surfaxin from Discovery for southern European territories, Latin America
Read More
Quarterly highlights at Isis underline commercial potential of antisense compounds
Read More
Human Genome Sciences reports results for third quarter
Read More
Japanese researchers demonstrate ability of HGF variant to halt renal tumor progression
Read More
NeXstar research leads to identification of new target for treating renal disease
Read More
New HOPE for high-risk patients with cardiovascular disease
Read More
Novel agents for renal diseases with benzimidazole structure
Read More
News from AHA: photoangioplasty with Antrin is safe and effective for PAD
Read More
Apoptosis inhibitors from JT useful for HIV infection and hepatitis
Read More
Modulators of MDR in development at Nikken Chemicals
Read More
Prognox effectively detects hypoxic tissue; kinetics differ in stunned and hibernating myocardium
Read More
Acetamide derivatives as chymase inhibitors patented by Nippon Kayaku
Read More
Taiho prepares novel agents for periodontitis
Read More
Etanidazole + radiosurgery for brain tumors fails to improve survival compared to radiosurgery alone
Read More
Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA
Read More
Clinical results for Enbrel in heart failure presented at AHA Scientific Sessions
Read More
Preclinical and interim clinical data presented for CN-706 at ASTRO
Read More
Combined data from three clinical trials of ibritumomab tiuxetan confirm safety in NHL
Read More
INTEGRITI study will evaluate fibrinogen antagonist/thrombolytic combination
Read More
Important new indication for Remicade approved by FDA
Read More
Insulin sensitizer improves cardiac function in diabetic mice
Read More
ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar
Read More
Canadian launch announced by Draxis for antispastic drug
Read More
Synergistic effects Na+/H+ exchange inhibitor and K(ATP) channel opener in MI
Read More
Synvisc under study for osteoarthritis of the hip
Read More
